Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement.

Dou D, Revol R, Östbye H, Wang H, Daniels R. · 2018

Read Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement. by Dou D, Revol R, Östbye H, Wang H, Daniels R. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6062596.txt.

Introduction

Dou and co-authors review how influenza A virus completes its life cycle. Their review appeared in Frontiers in Immunology. Unusually for an RNA virus, influenza copies itself in the cell nucleus. Its genome splits into eight separate segments. Each segment must cross cell membranes at entry and exit.

The review follows the virus step by step. Entry and nuclear import come first. Replication and assembly follow. New particles then move between cells. Viral and host machinery share the work at each stage. Open questions about coordination get flagged. Readers get a mechanistic map of infection. It shows where future drugs might block the cycle.

Catalog record

CREATORDou D, Revol R, Östbye H, Wang H, Daniels R.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE98 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6062596

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement By Dan Dou, Rebecca Revol, Henrik Östbye, Hao Wang, Robert Daniels Published in: Frontiers in Immunology DOI: 10.3389/fimmu.2018.01581 ABSTRACT Influenza viruses replicate within the nucleus of the host cell. This uncommon RNA virus trait provides influenza with the advantage of access to the nuclear machinery during replication. However, it also increases the complexity of the intracellular trafficking that is required for the viral components to establish a productive infection. The segmentation of the influenza genome makes these additional trafficking requirements especially challenging, as each viral RNA (vRNA) gene segment must navigate the network of cellular membrane barriers during the processes of entry and assembly. To accomplish this goal, influenza A viruses (IAVs) utilize a combination of viral and cellular mechanisms to coordinate the transport of their proteins and the eight vRNA gene segments in and out of the cell. The aim of this review is to present the current mechanistic understanding for how IAVs facilitate cell entry, replication, virion assembly, and intercellular movement, in an effort to highlight some of the unanswered questions regarding the coordination of the IAV infection process. INFLUENZA VIRUSES Influenza viruses belong to the Orthomyxoviridae family and are classified as either type A, B, C, or the recently identified type D (1, 2). Influenza A viruses (IAVs) and type B viruses (IBVs) contain 8, negative-sense, single-stranded viral RNA (vRNA) gene segments (Figure 1A) (3, 4), which encode transcripts for 10 essential viral proteins, as well as several strain-dependent accessory proteins (Figure 1B). In comparison, influenza type C and D viruses only possess seven vRNA gene segments, as the hemagglutinin–esterase fusion protein vRNA replaces the hemagglutinin (HA or H) and the neuraminidase (NA or N) vRNAs (1, 2). IAVs will be the main focus of this review since they are the primary agents responsible for influenza pandemics, and a major contributor to the annual influenza epidemics in the human population (5). [Figure: Influenza A and B viruses. (A) Schematic of the eight viral RNA (vRNA) gene segments that comprise the influenza A and B genomes. The 5′ and 3′ untranslated regions (UTRs), which contain the viral promoters, are represented with a line, and the box corresponds to the coding region within each vRNA. (B) Diagram of the viral mRNAs that are transcribed from the IAV (left) and IBV (right) vRNA templates. Boxes indicate the viral gene product encoded by each mRNA and the dashed lines show the alternative splicing of the IAV M and NS transcripts, as well as the IBV NS transcript. Red circles represent the 5′ M7pppG cap, black lines denote the 10–13 nucleotide, host-derived primers that are obtained by the cap-snatching mechanism of the viral polymerase. A(n) corresponds to the 3′ poly-A tail produced by reiterative stuttering of the viral polymerase. The smaller mRNAs (empty boxes) represent transcripts that encode nonessential accessory proteins found in many strains, whereas those that are less prevalent (PB2-S1, M42, and NS3) are not illustrated (6–11). (C) Diagram of an influenza A or B virus. The viral membrane proteins HA, NA, and M2 are shown, along with the eight viral ribonucleoproteins (vRNPs), and the matrix protein M1 that supports the viral envelope. To highlight the vRNP components, the illustration beneath the virus is not to scale. A single vRNA gene segment is shown wrapped around multiple nucleoprotein (NP) copies with the conserved promoter regions in the 5′ and 3′ UTRs forming a helical hairpin, which is bound by a single heterotrimeric viral RNA-dependent RNA polymerase (PB1, PB2, and PA). (D) Top view of an influenza virus cross-section showing the vRNP “1 + 7” configuration. vRNPs are depicted with black circles as it is not known if the positioning of a particular vRNP is conserved or interchangeable.] The natural reservoir for IAVs is wild aquatic birds, but they commonly infect other species, including humans, and have even been isolated from penguins in Antarctica (12–15). The ability to adapt to multiple species is a major reason why IAVs are more diverse than IBVs, which are essentially exclusive to humans. Despite the host-range differences, many similarities do exist between these two viruses. Both possess a host-derived lipid membrane, referred to as an envelope, which is decorated on the surface with the viral membrane proteins HA, NA, and to a lesser extent the matrix 2 (M2) protein (Figure 1C) (16–18). The envelope is supported underneath by the matrix 1 (M1) protein, and inside, the eight vRNAs are found as individual viral ribonucleoprotein (vRNP) complexes (Figure 1C, bottom). Each vRNP is comprised of a vRNA that is wrapped around numerous copies of the viral nucleoprotein (NP) and bound by a single copy of the heterotrimeric viral polymerase, consisting of PB1, PB2, and PA (19–21). The polymerase binds the vRNAs at a helical hairpin that results from the base pairing between the conserved semi-complimentary 5′ and 3′ ends (21–23). Morphologically, IAVs can either form spheres with a diameter of ~100 nm or filaments that can reach up to 20 µm in length [reviewed in Ref. (24)]. However, upon passaging in eggs, or MDCK cells, the filamentous form is generally lost (25, 26). Several studies have attributed the morphology change to M1, presumably through its function in supporting the envelope (27–29). Regardless of the virion shape, HA is the most abundant viral envelope protein, followed by NA, and M2 (30). Recent work has shown that the viral envelope also contains host membrane proteins (30, 31). These proteins are likely recruited based on the lipid composition at the plasma membrane budding site, which can differ between cell types (32, 33). Through possible interactions with each other and M1, the eight vRNPs typicallly form a 1 + 7 configuration inside the virus (Figure 1D) (34, 35). The 1 + 7 configuration may have a mechanistic function, as it is also conserved in type C and D viruses that only possess 7 vRNAs (36). Further supporting the mechanistic concept, it was recently shown that IAVs can package cellular ribosomal RNA (as a vRNP) when one of the vRNAs is made unavailable (37), possibly explaining how type C and D viruses acquire their “eighth” vRNA. The classification of IAVs into subtypes is based on the genetic and antigenic properties of the surface antigens HA and NA, which mediate viral entry and release, respectively (17, 18). To date, 16 HA (H1-16) and 9 NA subtypes (N1-9) have been found in IAVs isolated from aquatic birds (13). Two additional subtypes for HA (H17 and H18) and NA (N10 and N11) have recently been identified in bats (38, 39), but in contrast to the HA and NA subtypes from the more traditional avian IAVs, these do not appear to recognize sialic acid (SA) (40–42). Despite the numerous possible subtype combinations, only three have consistently persisted in the human population, causing the following pandemics in the process: 1918 and 2009 (H1N1), 1957 (H2N2), and 1968 (H3N2) (43). Currently, only the H1N1 and H3N2 subtypes, as well as the two antigenically distinct IBV lineages (Victoria and Yamagata), are endemic in the human population (44), which is why many IAV vaccines include two representative IAV and IBV strains (5). A significant challenge in battling IAVs is

Read the complete text